Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/LOE-TR-582

Vinylidene Chloride: Target Organs and Levels of Evidence for TR-582

Toxicology and Carcinogenesis Studies of Vinylidene Chloride (CASRN 75-35-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies)

Chemical
CASRN
(Study Title) 		Peer Review Date Primary Uses Route/Exposure Levels Study Laboratory
Vinylidene Chloride
75-35-4 		10/29/2013 Copolymerized with vinychloride or acrylonitrile for saran and saran fibers. A widely used chemical intermediate and monomer. Inhalation
R: 0, 25, 50, or 100 ppm; M: 0, 6.25, 12.5, or 25 ppm; 50/sex/species/dose 		Battelle Northwest Laboratory

Levels of Evidence

Male Rats: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • All Organs: malignant mesothelioma 1/50 12/50 28/50 23/50
  • Kidney: renal tubule carcinoma 0/50 2/50 1/49 1/50
  • Nasal Cavity: respiratory epithelium, adenoma 0/49 0/50 1/50 4/50
Non-Neoplastic Lesions
  • Nasal Cavity: turbinate, atrophy; turbinate, hyperostosis; olfactory epithelium, metaplasia, respiratory; respiratory epithelium, hyperplasia; inflammation, chronic active
  • Lung: alveolar epithelium hyperplasia
  • Liver: chronic inflammation; diffuse fatty change; cystic degeneration
Female Rats: Some Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Thyroid Gland C-Cell: adenoma 3/50 4/50 6/48 11/50; carcinoma 0/50 6/50 2/48 2/50 adenoma or carcinoma 3/50 10/50 8/48 13/50
  • All Organs: mononuclear cell leukemia 10/50 11/50 13/50 25/50
May Have Been Related
  • All Organs: malignant mesothelioma 0/50 1/50 1/50 0/50
Non-Neoplastic Lesions
  • Nasal Cavity: turbinate, atrophy; turbinate, hyperostosis; olfactory epithelium, metaplasia, respiratory; respiratory epithelium, hyperplasia; inflammation, chronic active
  • Liver: chronic inflammation; diffuse fatty change; cystic degeneration; necrosis
Male Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Kidney: renal tubule adenoma 0/50 5/50 19/50 10/50 renal tubule carcinoma 0/50 7/50 31/50 18/50 renal tubule adenoma or carcinoma 0/50 11/50 37/50 27/50
May Have Been Related
  • Liver: hepatocholangiocarcionoma 1/50 2/50 2/50 3/50
Non-Neoplastic Lesions
  • Kidney: renal tubule hyperplasia
  • Nasal Cavity: turbinate, atrophy; hyperostosis; olfactory epithelium, metaplasia, respiratory; olfactory epithelium, accumulation, hyaline droplet
Female Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • All Organs: hemangioma or hemangiosarcoma 4/50 6/50 6/50 11/50
  • Liver: hepatocellular adenoma 25/50 21/50 36/50 29/50 hepatocellular carcinoma 8/50 14/50 12/50 17/50 hepatocellular adenoma or carcinoma 28/50 30/50 37/50 38/50 hepatocholangiocarcinoma 0/50 1/50 1/50 2/50
May Have Been Related
  • Lung: alveolar/bronchiolar carcinoma 1/50 2/50 7/50 5/49
  • Intestines (Small): (Ileum): carcinoma 1/50 1/50 1/50 3/50
Non-Neoplastic Lesions
  • Nasal Cavity: turbinate, atrophy; hyperostosis; olfactory epithelium, metaplasia, respiratory; olfactory epithelium, accumulation, hyaline droplet; respiratory epithelium, hyperplasia